TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics

Recruiting now · Not applicable

Conditions studied: Lung Neoplasms

In brief

Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer. Aim 2: Assess the feasibility, acceptability, and implementation potential of the culturally adapted TELESCOPE intervention delivered by bilingual patient navigators for Hispanics. Hypothesis 1: The investigators expect a recruitment rate of ≥60%, ≥90% of Hispanic participants will complete the 1-week follow-up assessments, ≥80% of the key intervention components will be delivered with 80% fidelity by the patient navigators, and ≥90% of participants and clinicians will agree or completely agree that the intervention was feasible and acceptable. Aim 3: Explore the impact of a culturally adapted TELESCOPE intervention delivered by bilingual patient navigators vs enhanced usual care (EUC) on the initial uptake of low-dose computed tomography (LDCT) and quality of the shared decision-making (SDM) process. Hypothesis 2: The investigators expect that an adapted TELESCOPE intervention will result in higher uptake of LDCT and higher SDM quality for lung cancer screening (LCS) compared to EUC.

Key facts

Study ID

NCT07165691

Run by

Rutgers, The State University of New Jersey

People needed

91

Starts

2025-09-11

Expected to finish

2027-06-30

Last updated by the study team

2025-12-02

Who can join

Age: 50 and older, up to 77. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aim 1 (Cultural Adaptation):
• To be eligible, patients must:
• Identify as Hispanic and/or Latino(a)
• Able to read and speak in English or Spanish
• Be 50 to 77 years of age
• Be a current or former smoker
• Have at least a 20-pack-year smoking history
• Aims 2-3 (Pilot Randomized Controlled Trial)
• To be eligible, patients must:
• Identify as Hispanic or Latino(a)
• Able to speak and read in English or Spanish
• Be 50 to 77 years of age
• Be a current or former smoker having quit within the past 15 years
• Have at least a 20 pack-year smoking history
• Be scheduled for a non-acute care visit at one of the study sites.
• Not coughing up blood in the last two weeks
• Interviews
• Providers completing the semi-structured interviews will be:
• A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator at one of the participating sites, or a TELESCOPE study patient navigator and nurse navigator
• Age 18 or older
• Fluent in English
• Online surveys
• Providers completing online PRISM construct surveys will be:
• A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
• Age 18 or older

You may not qualify if…

• For the cluster randomized trial, excluded will be patients who:
• Do not speak English
• Are not Hispanic or Latino(a)
• Have a history of lung cancer
• Had a CT scan in the past 12 months
• Has been coughing up blood in the last two weeks
• Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider,
• Are unable to provide informed consent Interviews
• Providers/administrators will be excluded if they:
• Are unable to provide informed consent Online surveys
• Are unable to provide informed consent
• Women who are pregnant.

Where it is running

• Rutgers Cancer Institute — New Brunswick, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.